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SHOULD PORTASYSTEMIC SHUNTS BE AVOIDED IN
POTENTIAL LIVER TRANSPLANT CANDIDATES?
ABSTRACT
Brems, J.J. Hiatt, J. R. Klein, A. S. Millis, J.M. Colonna, J. O.
Quinones-Baldrich, W.J., Ramming, K.P. and Busuttil, R.W. (1989) Effect of a
prior portasystemic shunt on subsequent liver transplantation. Annals of Surgery,
209, 51-56
Fifteen patients who had a prior portasystemic shunt underwent orthotopic liver
transplantation. Shunt types were portacaval in six patients, II-graft mesocaval in
six, distal splenorenal in two, and proximal splenorenal in one. Mean blood loss and
hospital stay were highest in the portacaval group. Retransplants (two patients) and
deaths (two patients) also were limited to this group. In this report, technical
considerations, advantages, and disadvantages of the various shunt types are
described. Management of patients with late stages of portal hypertension must
include estimation of the effects of a portasystemic shunt on subsequent liver
transplantation. It is concluded that portacaval shunts should be avoided in patients
who may be considered for transplantation. Distal splenorenai shunts are best
performed in younger patients with intractable variceal bleeding who are not
expected to require transplantation in the near future. A mesocaval II-graft is the
shunt of choice in patients who are current liver transplant candidates.
PAPER DISCUSSION
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The recent publication from Brems, J., et al. underscores the importance of
clinical investigation into the relationship between the treatment of variceal
bleeding and the practice of hepatic transplantation. This deficit is due to two
problems in clinical hepatology. First, there has been a lack of involvement by
many transplant groups in the pre-transplant management of patients with liver
disease. Second, groups investigating the treatment of portal hypertension, even in
recent prospective trials2, have not considered the importance of OLT either as an
endpoint in the failure of other treatment for portal hypertension, or as one of the
available treatments for portal hypertension.
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of 15 patients with prior porto-systemic shunting. The authors are to be congratu-
lated for their excellent results in performing OLT in this technically challenging
subgroup of candidates. Until recently these patients were excluded as candidates
by some centers regarding such surgery as technical contra-indications.
The authors experienced extreme technical difficulties, and poor results in the
subgroup with previous porto-caval shunt, and therefore, recommended that this
operation be avoided in potential transplant candidates. While this is a reasonable
recommendation, it is not clear that their data permit this conclusion. The authors
do not clarify whether the shunt operations were performed by their own surgical
team as part of the management of the pre-transplant complications. They also fail
to discuss the role of the underlying liver disease (chronic hepatitis was the
predominant diagnosis in the porto-caval shunt group). It has recently become
clear that liver transplantation for parenchymal cirrhosis is associated with greater
technical difficulties, blood loss, and a higher mortality than cholestatic cirrhosis. In
addition, the clinical context prior to shunting usually influences the choice of the
procedure. Ascites, regarded as a contra-indication to selective shunting, has been
identified as a factor associated with poor prognosis in both the natural history of
liver disease and with increase risk after OLT. It is therefore likely that the patient
receiving porto-caval shunts had more severe liver disease and a higher risk for
OLT.
Based on a recent report evaluating the incidence of previous variceal bleeding in
1000 liver transplants at the University of Pittsburgh, the authors recommended
abandonment of portosystemic shunting as an option in the treatment of liver
disease3. The use of retrospective data to make these recommendations was
seriously questioned by Wexler in the discussion published with the report.
Clarification of the role of hepatic transplantation and portal decompression will
require the prospective analysis of populations with portal hypertension, not the
retrospective evaluation of a subgroup of liver transplant recipients previously
treated for variceal bleeding. Equally important, prospective study of portal
hypertension therapy must include liver transplantation both as an option in the
management of variceal bleeding, and as an endpoint in patients with treatment
failure after sclerosis or shunt therapy.
At the present time, we feel it is more appropriate to consider shunt surgery as
one of the palliative options in most patients with liver disease. Shunts should
therefore, be performed with the consideration of future transplant therapy in
which avoidance of the hepatic hilus is probably advisable. It should not be
forgotten, however, that shunt surgery is potentially curative therapy in non-
progressive or potentially reversible liver disease and will continue to have a role in
modern surgery4.
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